Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity

OBJECTIVE: To investigate the influence of heterogeneity in disease progression for detecting treatment effects in Alzheimer disease (AD) trials, using a simulation study. METHODS: Individuals with an abnormal amyloid PET scan, diagnosis of mild cognitive impairment or dementia, baseline Mini-Mental...

Descripción completa

Detalles Bibliográficos
Autores principales: Jutten, Roos J., Sikkes, Sietske A.M., Van der Flier, Wiesje M., Scheltens, Philip, Visser, Pieter Jelle, Tijms, Betty M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205463/
https://www.ncbi.nlm.nih.gov/pubmed/34550903
http://dx.doi.org/10.1212/WNL.0000000000012022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205463/
https://www.ncbi.nlm.nih.gov/pubmed/34550903
http://dx.doi.org/10.1212/WNL.0000000000012022

Ejemplares similares